Brief: Galderma Receives U.S. FDA Approval For Restylane Contour For The Correction Of Temple Hollowing

Galderma AG

23/03/2026 06:02

March 23 (Reuters) - GALDERMA GROUP AG GALD.S:

RECEIVES U.S. FDA APPROVAL FOR RESTYLANE® CONTOUR™ FOR CORRECTION OF TEMPLE HOLLOWING

U.S. FDA HAS APPROVED RESTYLANE CONTOUR FOR CORRECTION OF TEMPLE HOLLOWING IN PATIENTS OVER AGE OF 21

Source text: ID:nBw73clcha

Further company coverage: GALD.S

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))